The global protein A resin market is witnessing a surge in demand due to its ability to bind antibodies. Protein A resin is a recombinant protein used to purify monoclonal antibodies. It is used extensively in biopharmaceuticals, diagnostics, and research laboratories. The global protein A resin market in terms of revenue was estimated to be worth $1.1 billion in 2020 and is poised to reach $1.9 billion by 2025, growing at a CAGR of 11.4% from 2020 to 2025.
Browse in-depth TOC on “Protein A Resin Market”
103 – Tables
42 – Figures
137 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19196962
The increasing demand for monoclonal antibodies for therapeutic and diagnostic applications is expected to drive the growth of the global protein A resin market. Additionally, the growing number of biopharmaceutical companies and the rising demand for protein A resin from research laboratories are key factors driving the growth of the global protein A resin market.
Key Market Players
The prominent players in the global protein A resin market include GE Healthcare (US), Merck Millipore (Germany), Repligen Corporation (US), Thermo Fisher Scientific (US), Tosoh Bioscience (Japan), Purolite Corporation (US), Novasep Holding SAS (France), Agilent Technologies (US), GenScript Biotech Corporation (China), PerkinElmer (US), Bio-Rad Laboratories (US), Orochem (US), Kaneka Corporation (Japan), Abcam (UK), Agarose Bead Technologies (US), Avantor (US), JSR Life Sciences (US), Bio-Works Technologies (Sweden), Amikozen Co. Ltd. (US), and Takara Bio Inc. (Japan).
The global protein A resin market is segmented by end user into biopharmaceuticals, diagnostics, and research laboratories. The biopharmaceuticals segment is expected to hold the largest share of the global protein A resin market, due to the increased demand for monoclonal antibodies for therapeutic and diagnostic applications.
The global protein A resin market is further segmented by region into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to dominate the global protein A resin market, due to the presence of a large number of biopharmaceutical companies in the region.
North America to dominate the market
North America, Europe, Asia Pacific, and the Rest of the World (RoW) are the regions considered for geographic analysis of the global protein A resin market study. North America is expected to account for the largest share of the global market. The large share of North America is attributed to the A strong monoclonal antibody therapeutics market in North America is the key driver for the Recombinant protein A market in the region.
The global protein A resin market is expected to witness a steady growth in the coming years, due to the increasing demand for monoclonal antibodies and the growing number of biopharmaceutical companies. Companies are focusing on developing new products to strengthen their market position and gain a competitive edge.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=19196962
This research report categorizes the protein A ?resin market based on product, type, application, end user, and region.
By Product
By Type
By Application
By End-User
By Region
Recent Developments
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=19196962
Media ContactCompany Name: MarketsandMarkets™ Research Private Ltd.Contact Person: Mr. Aashish MehraEmail: Send EmailPhone: 18886006441Address:630 Dundee Road Suite 430City: NorthbrookState: IL 60062Country: United StatesWebsite: https://www.marketsandmarkets.com/Market-Reports/protein-a-resin-market-19196962.html